StonvexLoading…
StonvexStonvexStonvexCore line items from ALTI's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Annual 2025 2025-12-31 | Annual 2024 2024-12-31 | Annual 2023 2023-12-31 | Annual 2022 2022-12-31 |
|---|---|---|---|---|
Revenue | $254.96M | $198.39M | $221.15M | $76.87M |
Operating Income | $-73.94M | $-58.93M | $-48.23M | $-1.32M |
Net Income | $-119.70M | $-103.03M | $-165.58M | $-5.88M |
EPS (Diluted) | $-1.23 | $-1.59 | $-2.70 | $-839.87 |
Total Assets | $1.18B | $1.26B | $1.27B | $91.99M |
Total Liabilities | $301.66M | $285.64M | $483.80M | $74.14M |
Cash & Equivalents | $41.16M | $64.42M | $15.35M | $7.13M |
Free Cash Flow OCF − CapEx | $-52.24M | $-58.21M | $-82.04M | $6.70M |
Shares Outstanding | 99.87M | 79.69M | 115.82M | 7.01K |